Name: Rallybio Corporation (RLYB) Financial Statements
Creator: FinSpry

Rallybio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Rallybio Corporation income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.64	0.00	0.00	0.00	0.00
Cost of Revenue	39.51	53.54	0.00	0.00	0.00
Gross Profit	-38.87	-53.54	0.00	0.00	0.00
Operating Expenses
Research & Development	41.51	53.54	40.69	26.91	17.63
Selling, General & Administrative	19.63	25.39	27.20	18.74	7.67
Operating Expenses	61.13	78.93	67.88	45.65	25.30
Operating Income	-60.50	-78.93	-67.88	-45.65	-25.30
Other Income/Expense
Interest Income	4.22	6.15	1.96	0.05	0.17
Interest Expense	0.00	0.00	0.00	-0.01	-0.05
Other Income/Expense	-1.50	1.55	-0.73	1.41	0.24
Income
Income Before Tax	-57.78	-72.52	-66.65	-45.51	-26.46
Income Tax Expense	0.00	0.00	0.00	0.00	-0.02
Net Income	-57.78	-74.56	-66.65	-47.01	-26.45
Net Income - Continuous Operations	-57.78	-74.56	-66.65	-47.01	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-60.37	-77.50	-67.72	-45.39	-25.24
EBIT	-60.50	-74.56	-67.88	-45.50	-25.30
Depreciation & Amortization	0.13	0.10	0.20	0.10	0.06
Earnings Per Share
Basic EPS	-1.00	-2.00	-2.00	-2.00	-12.00
Diluted EPS	-1.00	-2.00	-2.00	-2.00	-12.00
Basic Shares Outstanding	43.54	40.45	31.82	25.52	2.17
Diluted Shares Outstanding	43.54	40.45	31.82	3.19	2.17